Victory Capital Management
CLB icon

Victory Capital Management’s Core Laboratories CLB Stock Holding History

Victory Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,464
Closed -$324K – 2711
2022
Q1 		$324K Buy
+12,464
New +$349K ﹤0.01% 2268
2020
Q3 		– Sell
-29,678
Closed -$603K – 2500
2020
Q2 		$603K Sell
29,678
-6,711
-18% -$120K ﹤0.01% 1927
2020
Q1 		$376K Buy
36,389
+1,134
+3% +$31.7K ﹤0.01% 1940
2019
Q4 		$1.33M Buy
35,255
+3,823
+12% +$172K ﹤0.01% 1656
2019
Q3 		$1.47M Buy
31,432
+17,544
+126% +$816K ﹤0.01% 1584
2019
Q2 		$726K Sell
13,888
-1,086
-7% -$63.7K ﹤0.01% 1343
2019
Q1 		$1.03M Sell
14,974
-10,298
-41% -$690K ﹤0.01% 1241
2018
Q4 		$1.51M Sell
25,272
-83
-0.3% -$7.16K ﹤0.01% 1107
2018
Q3 		$2.94M Buy
+25,355
New +$2.86M 0.01% 1018

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Victory Capital Management's CLB Position: Q2 2022 in Review

Victory Capital Management sold out of Core Laboratories (CLB) in Q2 2022, closing a stake of 12,464 shares — an estimated $324K sold.

Victory Capital Management first reported a position in CLB in Q3 2018 and held it in 9 quarters. The position peaked at $2.94M in Q3 2018. 175 funds tracked by Wall St. Rank hold CLB as of Q2 2022.

  • Victory Capital Management reported no remaining Core Laboratories position as of Q2 2022 after selling out during the quarter.
  • Victory Capital Management sold 12,464 Core Laboratories shares in Q2 2022, an estimated $324K.
  • Victory Capital Management first reported a position in Core Laboratories in Q3 2018 and held it in 9 quarters.
  • Victory Capital Management's Core Laboratories position peaked at $2.94M in Q3 2018.
  • 175 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2022.

Based on Victory Capital Management's 13F filing for Q2 2022, filed 1 Aug 2022.